Genitourinary Cancer News

Asthma appeared associated with a 1.36-fold increased risk for developing cancer, according to research conducted at University of Florida.

Cancers with high vs. low tumor mutational burden appeared significantly associated with improved clinical outcomes among patients treated with immune checkpoint inhibitors, according to data published in JAMA Network Open.

Surgical excision of lymph nodes proved effective as first-line treatment for men with early metastatic testicular seminoma with clinically low-volume retroperitoneal lymphadenopathy, results of the phase 2 SEMS trial showed.

Knowledge, expectations and attitudes of patients with cancer about genomic tumor testing appeared to be associated with their respective education and income levels, according to a study published in JCO Precision Oncology.

A single infusion of ALLO-316 provided a high rate of disease control for patients with advanced or metastatic renal cell carcinoma, results from the phase 1 TRAVERSE trial showed.

The number of individuals diagnosed with and treated for cancer in the United States decreased 14% during 2020 compared with the previous year, a study published in JAMA Surgery showed.

The combination of gemcitabine and docetaxel conferred superior high-grade recurrence-free survival compared with standard therapy among adults with high-risk nonmuscle-invasive bladder cancer, results of a retrospective study showed.

Delirium appeared associated with higher ICU and hospital mortality, as well as increased length of stay, among critically ill patients with cancer, according to data published in JCO Oncology Practice.

In a phase 1 trial of mistletoe extract for patients with cancer, researchers at Johns Hopkins Kimmel Cancer Center found the therapy to not only be safe but also potentially beneficial to quality of life.

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.